» Articles » PMID: 24331928

Exo70 Isoform Switching Upon Epithelial-mesenchymal Transition Mediates Cancer Cell Invasion

Overview
Journal Dev Cell
Publisher Cell Press
Date 2013 Dec 17
PMID 24331928
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial-mesenchymal transition (EMT) is an important developmental process hijacked by cancer cells for their dissemination. Here, we show that Exo70, a component of the exocyst complex, undergoes isoform switching mediated by ESRP1, a pre-mRNA splicing factor that regulates EMT. Expression of the epithelial isoform of Exo70 affects the levels of key EMT transcriptional regulators such as Snail and ZEB2 and is sufficient to drive the transition to epithelial phenotypes. Differential Exo70 isoform expression in human tumors correlates with cancer progression, and increased expression of the epithelial isoform of Exo70 inhibits tumor metastasis in mice. At the molecular level, the mesenchymal-but not the epithelial-isoform of Exo70 interacts with the Arp2/3 complex and stimulates actin polymerization for tumor invasion. Our findings provide a mechanism by which the exocyst function and actin dynamics are modulated for EMT and tumor invasion.

Citing Articles

Molecular mechanisms of mTOR-mediated cisplatin response in tumor cells.

Maharati A, Rajabloo Y, Moghbeli M Heliyon. 2025; 11(1):e41483.

PMID: 39834411 PMC: 11743095. DOI: 10.1016/j.heliyon.2024.e41483.


ESRP2-microRNA-122 axis promotes the postnatal onset of liver polyploidization and maturation.

Bangru S, Chen J, Baker N, Das D, Chembazhi U, Derham J Genes Dev. 2025; 39(5-6):325-347.

PMID: 39794125 PMC: 11874994. DOI: 10.1101/gad.352129.124.


The discovery, function, and regulation of epithelial splicing regulatory proteins (ESRP) 1 and 2.

Derham J, Kalsotra A Biochem Soc Trans. 2023; 51(3):1097-1109.

PMID: 37314029 PMC: 11298080. DOI: 10.1042/BST20221124.


PCB: A pseudotemporal causality-based Bayesian approach to identify EMT-associated regulatory relationships of AS events and RBPs during breast cancer progression.

Sun L, Qiu Y, Ching W, Zhao P, Zou Q PLoS Comput Biol. 2023; 19(3):e1010939.

PMID: 36930678 PMC: 10057809. DOI: 10.1371/journal.pcbi.1010939.


METTL3 regulates breast cancer-associated alternative splicing switches.

Achour C, Bhattarai D, Groza P, Roman A, Aguilo F Oncogene. 2023; 42(12):911-925.

PMID: 36725888 PMC: 10020087. DOI: 10.1038/s41388-023-02602-z.


References
1.
Yanagisawa M, Huveldt D, Kreinest P, Lohse C, Cheville J, Parker A . A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease. J Biol Chem. 2008; 283(26):18344-54. PMC: 2440599. DOI: 10.1074/jbc.M801192200. View

2.
Murphy D, Courtneidge S . The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol. 2011; 12(7):413-26. PMC: 3423958. DOI: 10.1038/nrm3141. View

3.
Feltes C, Kudo A, Blaschuk O, Byers S . An alternatively spliced cadherin-11 enhances human breast cancer cell invasion. Cancer Res. 2002; 62(22):6688-97. View

4.
Goswami S, Philippar U, Sun D, Patsialou A, Avraham J, Wang W . Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo. Clin Exp Metastasis. 2008; 26(2):153-9. PMC: 3042857. DOI: 10.1007/s10585-008-9225-8. View

5.
Dittmar K, Jiang P, Park J, Amirikian K, Wan J, Shen S . Genome-wide determination of a broad ESRP-regulated posttranscriptional network by high-throughput sequencing. Mol Cell Biol. 2012; 32(8):1468-82. PMC: 3318588. DOI: 10.1128/MCB.06536-11. View